These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 8808593

  • 1. Twenty-year outcome analysis of genetic screening programs for Tay-Sachs and beta-thalassemia disease carriers in high schools.
    Mitchell JJ, Capua A, Clow C, Scriver CR.
    Am J Hum Genet; 1996 Oct; 59(4):793-8. PubMed ID: 8808593
    [Abstract] [Full Text] [Related]

  • 2. The frequency of Tay-Sachs disease causing mutations in the Brazilian Jewish population justifies a carrier screening program.
    Rozenberg R, Pereira Lda V.
    Sao Paulo Med J; 2001 Jul 05; 119(4):146-9. PubMed ID: 11500789
    [Abstract] [Full Text] [Related]

  • 3. Carrier screening for cystic fibrosis, Gaucher disease, and Tay-Sachs disease in the Ashkenazi Jewish population: the first 1000 cases at New York University Medical Center, New York, NY.
    Kronn D, Jansen V, Ostrer H.
    Arch Intern Med; 1998 Apr 13; 158(7):777-81. PubMed ID: 9554684
    [Abstract] [Full Text] [Related]

  • 4. Prenatal genetic carrier testing using triple disease screening.
    Eng CM, Schechter C, Robinowitz J, Fulop G, Burgert T, Levy B, Zinberg R, Desnick RJ.
    JAMA; 1997 Oct 15; 278(15):1268-72. PubMed ID: 9333269
    [Abstract] [Full Text] [Related]

  • 5. Joint SOGC-CCMG Opinion for Reproductive Genetic Carrier Screening: An Update for All Canadian Providers of Maternity and Reproductive Healthcare in the Era of Direct-to-Consumer Testing.
    Wilson RD, De Bie I, Armour CM, Brown RN, Campagnolo C, Carroll JC, Okun N, Nelson T, Zwingerman R, Audibert F, Brock JA, Brown RN, Campagnolo C, Carroll JC, De Bie I, Johnson JA, Okun N, Pastruck M, Vallée-Pouliot K, Wilson RD, Zwingerman R, Armour C, Chitayat D, De Bie I, Fernandez S, Kim R, Lavoie J, Leonard N, Nelson T, Taylor S, Van Allen M, Van Karnebeek C.
    J Obstet Gynaecol Can; 2016 Aug 15; 38(8):742-762.e3. PubMed ID: 27638987
    [Abstract] [Full Text] [Related]

  • 6. Genetic screening for reproductive purposes at school: is it a good strategy?
    Frumkin A, Zlotogora J.
    Am J Med Genet A; 2008 Jan 15; 146A(2):264-9. PubMed ID: 18080324
    [Abstract] [Full Text] [Related]

  • 7. Community genetics and dignity in diversity in the Quebec Network of Genetic Medicine.
    Scriver CR.
    Community Genet; 2006 Jan 15; 9(3):142-52. PubMed ID: 16741343
    [Abstract] [Full Text] [Related]

  • 8. Tay Sachs disease in Australia: reduced disease incidence despite stable carrier frequency in Australian Jews.
    Lew RM, Proos AL, Burnett L, Delatycki M, Bankier A, Fietz MJ.
    Med J Aust; 2012 Dec 10; 197(11):652-4. PubMed ID: 23230938
    [Abstract] [Full Text] [Related]

  • 9. Multimedia messages in genetics: design, development, and evaluation of a computer-based instructional resource for secondary school students in a Tay Sachs disease carrier screening program.
    Gason AA, Aitken M, Delatycki MB, Sheffield E, Metcalfe SA.
    Genet Med; 2004 Dec 10; 6(4):226-31. PubMed ID: 15266211
    [Abstract] [Full Text] [Related]

  • 10. Population programs for the detection of couples at risk for severe monogenic genetic diseases.
    Zlotogora J.
    Hum Genet; 2009 Aug 10; 126(2):247-53. PubMed ID: 19390864
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Assessing the potential success of cystic fibrosis carrier screening: lessons learned from Tay-Sachs disease and beta-thalassemia.
    Laberge AM, Watts C, Porter K, Burke W.
    Public Health Genomics; 2010 Aug 10; 13(5):310-9. PubMed ID: 19864874
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A private view of heterozygosity: eight-year follow-up study on carriers of the Tay-Sachs gene detected by high school screening in Montreal.
    Zeesman S, Clow CL, Cartier L, Scriver CR.
    Am J Med Genet; 1984 Aug 10; 18(4):769-78. PubMed ID: 6486173
    [Abstract] [Full Text] [Related]

  • 15. A pseudodeficiency allele common in non-Jewish Tay-Sachs carriers: implications for carrier screening.
    Triggs-Raine BL, Mules EH, Kaback MM, Lim-Steele JS, Dowling CE, Akerman BR, Natowicz MR, Grebner EE, Navon R, Welch JP.
    Am J Hum Genet; 1992 Oct 10; 51(4):793-801. PubMed ID: 1384323
    [Abstract] [Full Text] [Related]

  • 16. ACOG committee opinion. Number 318, October 2005. Screening for Tay-Sachs disease.
    ACOG Committee on Genetics.
    Obstet Gynecol; 2005 Oct 10; 106(4):893-4. PubMed ID: 16199656
    [Abstract] [Full Text] [Related]

  • 17. Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease.
    Hussein N, Weng SF, Kai J, Kleijnen J, Qureshi N.
    Cochrane Database Syst Rev; 2015 Aug 12; 2015(8):CD010849. PubMed ID: 26264938
    [Abstract] [Full Text] [Related]

  • 18. Screening for carriers of Tay-Sachs disease in the ultraorthodox Ashkenazi Jewish community in Israel.
    Broide E, Zeigler M, Eckstein J, Bach G.
    Am J Med Genet; 1993 Aug 15; 47(2):213-5. PubMed ID: 8213907
    [Abstract] [Full Text] [Related]

  • 19. Carrier testing for autosomal-recessive disorders.
    Vallance H, Ford J.
    Crit Rev Clin Lab Sci; 2003 Aug 15; 40(4):473-97. PubMed ID: 14582604
    [Abstract] [Full Text] [Related]

  • 20. Tay-Sachs disease--carrier screening, prenatal diagnosis, and the molecular era. An international perspective, 1970 to 1993. The International TSD Data Collection Network.
    Kaback M, Lim-Steele J, Dabholkar D, Brown D, Levy N, Zeiger K.
    JAMA; 1993 Nov 17; 270(19):2307-15. PubMed ID: 8230592
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.